Background. Several metallic intracoronary stents are currently undergoing preliminary evaluation to ascertain potential benefit as means to reduce the 30-40% incidence of restenosis after balloon angioplasty.
Methods and Results. To determine the incidence and correlates of restenosis after placement of Palmaz-Schatz stents in native coronary arteries in the first group of patients selected for this procedure, clinical and quantitative angiographic data from 206 consecutive patients (221 stenoses) with successful stent placement (diameter stenosis <50%Y) were analyzed. Six patients (2.9%) had thrombosis-mediated stent closure within 1 month after stent placement and were excluded from long-term angiographic follow-up. One hundred eighty-one (91%) of the remaining 200 patients had angiography at 5.8±2.1 months. Patients with and without follow-up did not differ in any baseline characteristic; in particular, history of restenosis at the site stented (73% versus 65%), placement of multiple overlapping stents (17% versus 20%), and mean poststent diameter stenosis (16±12% versus 14+12%). The overall incidence of restenosis (diameter stenosis .501% at follow-up) in this group at high risk for restenosis was 36%o (95% confidence interval, 29-43%) on a per-stenosis basis. The incidence of restenosis when a single stent was placed was 301% (95% confidence interval, 23-37%). Risk was dependent upon a history of restenosis (present versus absent 36%o versus 16%, p=0.02) and upon whether or not a poststent stenosis 0%Y was achieved (6% versus 33%,p=0.02). When multiple overlapping stents were placed, restenosis occurred at 64% of sites, and placement of multiple stents was discouraged during the later phases of this study as these results became apparent.
Conclusions. Although multiple stents appear to yield a poor long-term result, placement of single stents may offer a benefit compared with standard coronary angioplasty, particularly if an excellent angiographic result can be obtained in patients without prior restenosis. Further randomized trials in such patients are needed. (Circulation 1992; 86:1836 -1844 KEY WoRDs * angioplasty, coronary * stents * restenosis
In contrast to the dramatic increase in the primary success rate of coronary angioplasty,'-3 the longterm efficacy after a successful angioplasty has not improved since the first coronary procedure was performed in 1977.4 5This has been almost entirely due to an unabated restenosis rate of 30-40%, which has persisted despite multiple attempted pharmacological6-13 and mechanical'4,15 interventions.
The pathogenesis of restenosis is incompletely understood16 but is probably a multifactorial process that includes growth factor-stimulated smooth muscle cell proliferation,17-20 elastic recoil,21 and perhaps organization of thrombus adherent at the site of arterial injury. 22 As early as 1969, Dotter23 introduced the concept of maintaining vascular patency by endoluminal stenting. Inadequate design prevented widespread clinical application of such devices for many years. More recently, however, improvements in the design and technology have allowed extensive clinical investigation of several intracoronary stents. [24] [25] [26] [27] One of these, the Palmaz-Schatz stent, a refinement based on the original design of Palmaz,28,29 has been undergoing clinical evaluation since 1988. The purpose of this report is to define the overall incidence of restenosis in the first group of patients selected to undergo this procedure and to explore the clinical and procedural variables that may modify the risk of restenosis after stent implantation.
Methods

Patient Population
Consecutive patients who underwent successful native coronary artery stent implantation and who were eligible for 6-month angiographic follow-up by August 1, 1990 , are described in this report. The inclusion and exclusion criteria for patient enrollment into this trial in the United States as well as the early poststent results with this stent have been described. 25 Patients who received an earlier prototype rigid stent (the Palmaz stent) or who did not receive warfarin after hospital discharge were excluded.
Stent Design and Implantation
The Palmaz-Schatz stent is composed of two 7-mmlong slotted stainless steel tubes connected by a 1-mm bridging strut to allow for longitudinal flexibility. The individual strut diameter is 0.075 mm. When balloonexpanded, the stent slots take on a diamond configuration (see Figure 1 ) that resists compression and has very limited recoil. In animal models, the stent becomes covered with platelets and fibrin within minutes to hours after implantation and is fully endothelialized at 4 weeks. 29, 30 The technique of stent implantation has been described. 24 .50% diameter stenosis at follow-up.
Statistical Analysis
All data are expressed as mean±SD unless otherwise indicated. Group differences between continuous and categorical outcomes for normally distributed variables were assessed using the Student's t test and x2 analysis with Yates's correction where applicable, respectively. For variables with non-Gaussian distribution (e.g., poststent percent diameter stenosis), Kruskal-Wallis one-way ANOVA testing was used to assess differences in outcome. Effects were considered significant when the null hypothesis could be rejected with 95% confidence (twosided testing). Independent correlates of restenosis and significant luminal renarrowing were determined by multivariate logistic regression analysis and multivariate linear regression analyses, respectively. Only stenoses that had been quantitatively analyzed by using the ADAC system were used to determine the correlates of significant luminal renarrowing. The variables tested as possible correlates of these end points were limited to those previously shown from multiple studies to be correlates of postangioplasty restenosis34 and those shown in prior preliminary studies to correlate with restenosis after stenting31 in order to minimize the likelihood of a type I statistical error. The variables evaluated were chronic total occlusion, current smoking at the time of stent implantation, diabetes mellitus, sex, left anterior descending coronary artery stenosis, multiple stent implantation, normal arterial diameter adjacent to the segment stented, poststent percent diameter stenosis, prior restenosis at the site stented, optimal angiographic result, proximal vessel stenosis stented, and unstable angina pectoris. All analyses were performed using SYSTAT software.35 
Results
Baseline Patient and Stenosis Characteristics and Procedural Outcome
The characteristics of the patients and stenoses with and without angiographic follow-up are enumerated in Table 1 . There were no significant differences between patients with and without angiographic follow-up with respect to baseline characteristics or initial results. 
Correlates of Restenosis and Luminal Renarrowing
As shown in Tables 2 and 3 and Figures 2 and 3 , the placement of multiple overlapping stents was associated with a much higher incidence of restenosis and a greater luminal renarrowing than placement of a single stent (both multivariatep<0.001) and was the only significant independent correlate of restenosis. Figure 2 illustrates the apparent importance of stent overlap in the pathogenesis of luminal renarrowing. Patients with prior restenosis (p=0.01) or with chronic total occlusion (p=0.06) also had a higher likelihood of restenosis. The degree of luminal renarrowing was independently correlated with poststent percent diameter stenosis (greater displacement of the angiographically apparent stenosis) (p<0.001), the placement of multiple stents (p=0.002), and after angioplasty and stent placement in a previously chronically occluded artery (p=0.03).
Incidence and Correlates of Restenosis After Single-Stent Implantation
The incidence of restenosis after single-stent implantation was 30 .2% (95% confidence interval, 23.1-37.3%). The estimated likelihood of developing reste- nosis with standard percutaneous transluminal coronary angioplasty (PTCA) in this group according to the M-HEART nomograms3637 is 33%. In these stenoses, the history of previous restenosis (36% versus 16%, p=0.04) and poststent diameter stenosis .1% (33% versus 6%, p=0.05) independently and adversely affected the likelihood of restenosis (see Table 2 and Figure 3 ). When a .0% poststent diameter stenosis could be achieved, there was a 17% incidence (95% confidence limits, 2-32%) of restenosis with previously untreated lesions and a 0% incidence (95% confidence limits, 0-8%) of restenosis with restenotic lesions. In the stenoses treated with a single stent, only small poststent diameter stenosis correlated with a significant increase in luminal renarrowing (p=0.008) (see Table  3 ). been suggested that the passivation of stainless steel or other surfaces early after contact with blood elements may decrease thrombogenicity.55 Repeated stent-onstent trauma with overlapping stents might impair passivation, promote thrombus formation, and thereby increase the risk of restenosis (see Figure 2) .
A history of restenosis was also associated with a greater likelihood of restenosis after placement of a single Palmaz-Schatz stent (multivariate p=0.01). Restenosis, particularly soon after38 or multiple times after coronary angioplasty,39 appears to heighten the risk of restenosis after PTCA. These factors also increase the risk of restenosis after other coronary interventions such as atherectomy.56 Specimens retrieved and analyzed after atherectomy or at autopsy suggest that arterial trauma incites a change in the smooth muscle cell phenotype from contractile to synthetic,57'58 and it has been suggested that trauma to an area containing many phenotypically synthetic smooth muscle cells may heighten the risk of restenosis.
The extent of residual stenosis after stenting was highly correlated with the likelihood of subsequent restenosis. A stent dimension nearly approximating the adjacent vessel would provide a larger scaffold such that more myointimal hyperplasia would be required to encroach upon the normal lumen until a .50% diameter stenosis results. Importantly, however, a small residual stenosis was also correlated with increased myointimal regrowth, perhaps implying that at some dimension the effect of increased vessel wall stretch or trauma outweighed a possible benefit of lessened blood turbulence with its attendant tendency for less platelet deposition59 and perhaps release of platelet-derived growth factor(s). 54 Stent placement after angioplasty to a total occlusion also tended to have a higher likelihood of restenosis. Heightened risk of restenosis after PTCA of chronic total occlusions has been noted by several authors.60'6 Interestingly, other factors that have been demonstrated to heighten the risk of restenosis after standard PTCA such as left anterior descending stenosis location were not correlated with risk in this series, although the statistical power to detect multiple correlations of restenosis was low.
Mechanism of Possible Limitation of Restenosis by Single Stents
Although the 30% incidence of restenosis in lesions treated with a single stent might be considered encouraging when one considers that 90% of the stenoses treated might be considered moderate or high risk for restenosis on the basis of prior restenosis, left anterior descending site, or chronic total occlusion,34 it is impossible to know whether this was actually a better outcome than might have been achieved with standard balloon angioplasty. Only the data for de novo lesions appear particularly promising when one compares the results from this series with PTCA data such as those from the M-HEART group (see "Results"36 '37) . If, however, single stents do decrease the likelihood of restenosis, it would appear that this is most likely the result of an improvement in initial results compared with balloon angioplasty, not a decrease in the amount of recurrent narrowing after stenting. The concept of "acute gain, The implications of these results are multiple and must be understood in the context of the relatively high safety but finite risk of the procedure24: 1) There probably is no role for Palmaz-Schatz stent placement to prevent restenosis when multiple overlapping stents will be required, 2) randomized trials will be required to ascertain if the restenosis results achieved after singlestent placement are superior to those after coronary angioplasty alone and can be achieved with a low enough risk to be justifiable, 3) angioplasty operators should attempt to approximate the adjacent "normal" lumen diameter with stent placement, but given the increase in luminal renarrowing when a small final diameter stenosis was achieved noted in this study and experimental results linking myointimal proliferative response to stent-induced arterial trauma,67 caution must be urged not to vigorously overdilate stented arteries, and 4) given the apparent lack of reduction of luminal regrowth after stenting compared with PTCA alone, it appears that pharmacological means of limiting the proliferative response to injury will be required to further diminish the incidence of restenosis after balloon angioplasty. Finally, improvements in stent design that may markedly affect thrombogenicity and possibly restenosis are expected,68 and these results should not be generalized to all coronary stents.
